本文へ移動
cccskills
無料GitHub で公開

pdm-cgm-targets

This skill advises against using a single 24-hour CGM target <140 mg/dL when managing glucose in pregnancy for patients with preexisting diabetes. Trigger when a clinician is determining CGM-based glucose targets for pregnant individuals with type 1 or type 2 diabetes.

インストール方法を見る

含まれるファイル(1)

  • SKILL.md2.9 KB

SKILL.md(原文)

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Avoid single 24-hour CGM target in pregnancy with preexisting diabetes

STEP 1 — Gather Information

Collect: pregnancy confirmation, diabetes type (T1DM/T2DM), gestational age, current CGM metrics, proposed glucose target (e.g., single 24‑hour CGM target <140 mg/dL), maternal hypoglycemia history. Action: If data incomplete, obtain missing information before proceeding.

STEP 2 — Rule In / Rule Out

Is the clinician considering replacing standard pregnancy glucose targets with a single 24‑hour CGM target <140 mg/dL?

  • Yes → proceed to Step 3 (rule out the single target).
  • No → continue with standard targets; no further action needed for this skill.

STEP 3 — Classify or Stratify

Assess for safety of standard targets: check for history of severe hypoglycemia, hypoglycemia unawareness, or tight control that may increase risk.

  • If no contraindications → classify as appropriate for standard targets.
  • If contraindications present → flag for individualized targets (e.g., higher fasting threshold) and involve maternal‑fetal medicine; then proceed to Step 4 with adjusted targets.

STEP 4 — Decide

Recommend using the standard pregnancy glucose targets (fasting <95 mg/dL, 1‑hour postprandial <140 mg/dL, 2‑hour postprandial <120 mg/dL) for CGM‑guided management instead of a single 24‑hour target <140 mg/dL. Document the decision and educate the patient on target‑based insulin adjustments.

Clinical Guardrails / Mimics / Pitfalls

Do not use a single 24‑hour CGM target <140 mg/dL as a substitute for fasting and postprandial targets; avoid over‑reliance on time‑in‑range alone; be aware that hybrid closed‑loop algorithms may not achieve all three targets simultaneously; monitor for hypoglycemia when applying tight targets; consider individualized adjustments if maternal hypoglycemia occurs.

Concrete Clinical Example

A 32‑year‑old with type 1 diabetes at 18 weeks gestation plans to use CGM. The clinician initially considers a simple target of “keep glucose <140 mg/dL all day.” After gathering information (no hypoglycemia history, gestational age 18w), the rule‑out step triggers, classification finds no contraindications, and the decision is to advise fasting <95, 1‑hour <140, 2‑hour <120 mg/dL targets, with insulin adjustments based on pre‑meal and post‑meal readings.

Source: Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline, Endocrine Society and European Society of Endocrinology, 2025, DOI: 10.1210/clinem/dgaf288

TODO: consider adding scripts/calc.py for the pdm-cgm-targets calculator

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

同じリポジトリのスキル

概要と使いどころ

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する